Quantcast

Latest Janssen Inc. Stories

2014-09-17 08:28:44

New Treatment Option Combining Protease Inhibitor and Boosting Agent Reduces the Number of Pills Required to Manage HIV TORONTO, Sept. 17, 2014 /CNW/ - Janssen Inc. announced today that PREZCOBIX(TM) (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada.(1) It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet. "We...

2014-09-08 08:29:59

Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease TORONTO, Sept. 8, 2014 /CNW/ - Janssen Inc. (Janssen) today announced it has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto's Centre for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer's disease. The...

2014-05-26 08:22:34

INVOKANA((TM) )offers a new approach to treatment TORONTO, May 26, 2014 /CNW/ - Janssen Inc. announced today that Health Canada has approved INVOKANA((TM) )(canagliflozin), an oral, once-daily prescription treatment used to lower blood glucose (sugar) levels in adults with type 2 diabetes.(1) INVOKANA((TM) )belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors that offers a novel approach to treating diabetes by increasing the loss of...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related